Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000734977 | SCV000863162 | uncertain significance | not provided | 2018-08-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001247253 | SCV001420662 | uncertain significance | Bardet-Biedl syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 653 of the TRIM32 protein (p.Pro653Ser). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with TRIM32-related conditions. ClinVar contains an entry for this variant (Variation ID: 598557). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV000734977 | SCV003823466 | uncertain significance | not provided | 2019-11-23 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005047009 | SCV005682526 | uncertain significance | Sarcotubular myopathy; Bardet-Biedl syndrome 11 | 2024-01-03 | criteria provided, single submitter | clinical testing |